Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Minerva Neurosciences, Inc - Common Stock (NQ:NERV)

3.640 -0.180 (-4.71%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 111,838
Open 3.800
Bid (Size) 3.500 (200)
Ask (Size) 3.790 (200)
Prev. Close 3.820
Today's Range 3.530 - 3.810
52wk Range 1.150 - 12.46
Shares Outstanding 6,993,406
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga

Performance

YTD
+58.3%
+58.3%
1 Month
+67.0%
+67.0%
3 Month
+102.7%
+102.7%
6 Month
+126.1%
+126.1%
1 Year
+57.6%
+57.6%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Top movers in Wednesday's session
Via Chartmill
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
Minerva Neurosciences Stock Hits Near 2-Year High On FDA Pathway, $200M Boost — Retail Sees FDA Catalyst
Via Stocktwits
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial
Via Benzinga
These stocks are the most active in today's session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
US Stocks Mixed; Coca-Cola Posts Upbeat Earnings
Via Benzinga
These stocks that are showing activity before the opening bell on Tuesday.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation
From Minerva Neurosciences, Inc
Via GlobeNewswire
Unusual volume stocks are being observed in Wednesday's session.
Via Chartmill
Top movers in Wednesday's session
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results
From Minerva Neurosciences, Inc
Via GlobeNewswire
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via GlobeNewswire
Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via GlobeNewswire
NERV Stock Earnings: Minerva Neurosciences Misses EPS for Q2 2024
Via InvestorPlace
Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via GlobeNewswire
NERV Stock Earnings: Minerva Neurosciences Beats EPS for Q1 2024
Via InvestorPlace

Frequently Asked Questions

Is Minerva Neurosciences, Inc - Common Stock publicly traded?
Yes, Minerva Neurosciences, Inc - Common Stock is publicly traded.
What exchange does Minerva Neurosciences, Inc - Common Stock trade on?
Minerva Neurosciences, Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Minerva Neurosciences, Inc - Common Stock?
The ticker symbol for Minerva Neurosciences, Inc - Common Stock is NERV on the Nasdaq Stock Market
What is the current price of Minerva Neurosciences, Inc - Common Stock?
The current price of Minerva Neurosciences, Inc - Common Stock is 3.640
When was Minerva Neurosciences, Inc - Common Stock last traded?
The last trade of Minerva Neurosciences, Inc - Common Stock was at 11/06/25 04:00 PM ET
What is the market capitalization of Minerva Neurosciences, Inc - Common Stock?
The market capitalization of Minerva Neurosciences, Inc - Common Stock is 25.46M
How many shares of Minerva Neurosciences, Inc - Common Stock are outstanding?
Minerva Neurosciences, Inc - Common Stock has 25M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.